MedPath

重庆苯立方医药科技有限公司

Ownership
-
Established
2022-02-23
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20253859
Approval Date
Apr 8, 2025
NMPA

Mupirocin Ointment

Product Name
莫匹罗星软膏
Approval Number
国药准字H20253638
Approval Date
Mar 18, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.